196 related articles for article (PubMed ID: 27089613)
1. [Price of medications: the actual system must be seen again].
Mayencourt J
Rev Med Suisse; 2016 Mar; 12(508):479. PubMed ID: 27089613
[No Abstract] [Full Text] [Related]
2. [Medication prices in Germany--how are they determined?].
Bruhn C
Dtsch Med Wochenschr; 2010 Oct; 135(39):p34. PubMed ID: 20922657
[No Abstract] [Full Text] [Related]
3. State Initiatives to Control Medication Costs--Can Transparency Legislation Help?
Sarpatwari A; Avorn J; Kesselheim AS
N Engl J Med; 2016 Jun; 374(24):2301-4. PubMed ID: 27305189
[No Abstract] [Full Text] [Related]
4. Value-Based Pharmaceutical Contracts: Value for Whom?
Kannarkat JT; Good CB; Parekh N
Value Health; 2020 Feb; 23(2):154-156. PubMed ID: 32113619
[TBL] [Abstract][Full Text] [Related]
5. Drug-Pricing Debate Redux - Should Cost-Effectiveness Analysis Be Used Now to Price Pharmaceuticals?
Neumann PJ; Cohen JT; Ollendorf DA
N Engl J Med; 2021 Nov; 385(21):1923-1924. PubMed ID: 34767318
[No Abstract] [Full Text] [Related]
6. How to Reduce Prescription Drug Prices: First, Do No Harm.
Atlas S
Mo Med; 2020; 117(1):14-15. PubMed ID: 32158034
[No Abstract] [Full Text] [Related]
7. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
Gudiksen KL; King JS
J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534
[No Abstract] [Full Text] [Related]
8. Running short.
Mettner J
Minn Med; 2011 Oct; 94(10):8-10. PubMed ID: 23256277
[No Abstract] [Full Text] [Related]
9. New developments in pricing and drug reimbursement in France.
Pelc A; Castan JP
Pharmacoeconomics; 1994; 6 Suppl 1():28-35. PubMed ID: 10155583
[TBL] [Abstract][Full Text] [Related]
10. New prescription for the Spanish drug sector: fighting against public deficit without wasting ammunition.
Antoñanzas F; Gómez P
Pharmacoeconomics; 2010; 28(11):977-80. PubMed ID: 20936881
[No Abstract] [Full Text] [Related]
11. Who benefits from drug discounts? Drugmakers, hospitals battle over indigent-care program.
Lee J
Mod Healthc; 2013 Jul; 43(28):8-9. PubMed ID: 24044228
[No Abstract] [Full Text] [Related]
12. New rules for US drug reimbursement.
Bouchie A
Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382
[No Abstract] [Full Text] [Related]
13. Priced out of the UK market.
Moran N
Nat Biotechnol; 2008 Feb; 26(2):151-4. PubMed ID: 18259163
[No Abstract] [Full Text] [Related]
14. The internationalization of police: the DEA in Mexico.
Toro MC
J Am Hist; 1999; 86(2):623-40. PubMed ID: 21977561
[No Abstract] [Full Text] [Related]
15. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
[No Abstract] [Full Text] [Related]
16. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
[No Abstract] [Full Text] [Related]
17. Arbitration Board Setting Reimbursement Amounts for Pharmaceutical Innovations in Germany When Price Negations between Payers and Manufacturers Fail: An Empirical Analysis of 5 Years' Experience.
Ludwig S; Dintsios CM
Value Health; 2016 Dec; 19(8):1016-1025. PubMed ID: 27987628
[TBL] [Abstract][Full Text] [Related]
18. European pharmaceutical pricing and reimbursement conference.
Ehreth J; Williams D
Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):37-9. PubMed ID: 19371177
[TBL] [Abstract][Full Text] [Related]
19. Small gifts sustain sales.
Bausch J
Dtsch Arztebl Int; 2010 Jun; 107(22):390-1. PubMed ID: 20574554
[No Abstract] [Full Text] [Related]
20. Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues.
Dusetzina SB; Mello MM
N Engl J Med; 2018 Dec; 379(24):2290-2293. PubMed ID: 30428275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
